The impact of sex and gender on disease progression, from developmental origins

从发育起源来看性别和性别对疾病进展的影响

基本信息

  • 批准号:
    10260551
  • 负责人:
  • 金额:
    $ 57.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-10 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Abstract The maternal fetal interface is hormonal and immunologically rich environment that is important for normal placentation during the first trimester of pregnancy. This is also where adult diseases have developmental origins. Both the hormonal and immunologic milieus at this stage of gestation are already sexually dimorphic. We identified sexually dimorphic gene expression globally and among individual cell types of the first trimester placenta impacted by signaling at the maternal fetal interface, which includes members of the TGF-β superfamily, specifically TGFβ-1 and BMPs in males. Among individual cell types, ligands from the CCL family were most highly representative in females whereas IL1RN and MMP9 were highly expressed in males, with their corresponding receptors present on the maternal surface. Dihydrotestosterone, which is only produced by the male fetus, in addition to TGFβ1 and estradiol were identified as significant upstream regulators in individual cell types of the first trimester placenta. However, the hormonal environment may not be the only biologically sex different factor influencing the immune system, as we have also identified key transcription regulators in early gestation that may account for developmental origins of immune disease. Throughout the lifespan, hormones have been implicated to play a significant role in immune dysfunction and development of disease, as overall there is a higher prevalence of autoimmune diseases in females, such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis. Yet men are more likely to develop ankylosing spondylitis. Furthermore, males have increased prevalence of asthma compared to females in childhood, but the sexually dimorphic prevalence changes post-puberty, suggesting testosterone may be protective. There are also potential gender differences that influence the immune system. However, post puberty, hormonal regulation becomes sexually dimorphic again and it becomes difficult to separate the influence of hormones which is a function of biologic sex on the immune system from the influence of gender which is due to external influences. Therefore, in order to better understand the influence of biological sex during developmental origins of immune function, including the effect of the hormonal milieu, we intend to identify sex specific transcriptional regulatory signatures in the first trimester placenta. Furthermore, since sex hormones ar e not dimorphic in early childhood, prior to puberty, we intend to better understand the influence of gender on developmental differences of the immune system, prior to hormonal influences, to identify the critical drivers of sexual dimorphism in immune function. Our goal is to identify sex unique regulators of immune dysfunction that can ultimately be used as a more personalized approach to treating immunologic diseases.
摘要 母胎界面是激素和免疫丰富的环境,对于正常的 在怀孕的头三个月胎盘形成。这也是成人疾病在发展过程中 起源.在妊娠的这一阶段,激素和免疫环境都已经是两性异形的了。 我们发现,在妊娠的前三个月, 胎盘受到母体胎儿界面信号传导的影响,包括TGF-β超家族成员, 特别是TGFβ-1和BMP。在单个细胞类型中,来自CCL家族的配体最多。 在女性中高度代表性,而IL 1 RN和MMP 9在男性中高度表达, 相应的受体存在于母体表面。双氢睾酮,这是唯一产生的 除了TGFβ1和雌二醇外,男性胎儿也被确定为单个细胞中重要的上游调节因子。 第一孕期胎盘的类型。然而,荷尔蒙环境可能不是唯一的生物性别, 不同的因素影响免疫系统,因为我们还确定了关键的转录调节因子在早期 妊娠可能是免疫性疾病的发育起源。 在整个生命周期中,激素被认为在免疫功能障碍中起重要作用, 疾病的发展,因为总体而言,女性自身免疫性疾病的患病率较高,例如 系统性红斑狼疮、类风湿性关节炎和多发性硬化症。然而,男性更有可能发展为 强直性脊柱炎此外,与女性相比, 儿童期,但性二态患病率在青春期后发生变化,这表明睾酮可能是 保护性的还有潜在的性别差异会影响免疫系统。然而,Post 在青春期,荷尔蒙调节再次变得性二态化,并且很难将 激素的影响,这是一个功能的生物性别对免疫系统的影响, 这是由于外部的影响。 因此,为了更好地理解生物性别在发育起源中的影响, 免疫功能,包括激素环境的影响,我们打算确定性别特异性转录 在妊娠早期胎盘中的调节信号。此外,由于性激素在体内不是二态的, 在青春期之前的儿童早期,我们打算更好地了解性别对发育的影响, 免疫系统的差异,在激素影响之前,以确定性行为的关键驱动因素。 免疫功能的二型性。我们的目标是确定免疫功能障碍的性别独特调节因子, 最终将被用作治疗免疫性疾病的更个性化的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margareta Pisarska其他文献

Margareta Pisarska的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margareta Pisarska', 18)}}的其他基金

The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10469623
  • 财政年份:
    2020
  • 资助金额:
    $ 57.07万
  • 项目类别:
The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10687088
  • 财政年份:
    2020
  • 资助金额:
    $ 57.07万
  • 项目类别:
The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10062754
  • 财政年份:
    2020
  • 资助金额:
    $ 57.07万
  • 项目类别:
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts
基于循环滋养细胞的无创产前诊断
  • 批准号:
    10675005
  • 财政年份:
    2019
  • 资助金额:
    $ 57.07万
  • 项目类别:
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts
基于循环滋养细胞的无创产前诊断
  • 批准号:
    10252913
  • 财政年份:
    2019
  • 资助金额:
    $ 57.07万
  • 项目类别:
Noncoding RNA regulation of the human placental transcriptome among the sexes
性别中人胎盘转录组的非编码RNA调控
  • 批准号:
    9308742
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    8529827
  • 财政年份:
    2013
  • 资助金额:
    $ 57.07万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    9067824
  • 财政年份:
    2013
  • 资助金额:
    $ 57.07万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    8735977
  • 财政年份:
    2013
  • 资助金额:
    $ 57.07万
  • 项目类别:
Effects of fetal sex on the first trimester transcriptome
胎儿性别对妊娠早期转录组的影响
  • 批准号:
    8994647
  • 财政年份:
    2013
  • 资助金额:
    $ 57.07万
  • 项目类别:

相似海外基金

Dysregulation of Cytotoxic T Cell Exhaustion in Ankylosing Spondylitis
强直性脊柱炎中细胞毒性 T 细胞耗竭的失调
  • 批准号:
    488673
  • 财政年份:
    2023
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Operating Grants
Investigating the Role of T cell surface sialoglycans in Ankylosing spondylitis immunopathogenesis
研究 T 细胞表面唾液酸聚糖在强直性脊柱炎免疫发病机制中的作用
  • 批准号:
    486602
  • 财政年份:
    2022
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Studentship Programs
Prospective Evaluation of Autoimmune Ear Disease in Ankylosing Spondylitis & Spondyloarthritis
强直性脊柱炎自身免疫性耳病的前瞻性评估
  • 批准号:
    450958
  • 财政年份:
    2020
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Studentship Programs
T cell trafficking and specificity in ankylosing spondylitis
强直性脊柱炎中的 T 细胞运输和特异性
  • 批准号:
    380299
  • 财政年份:
    2018
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Operating Grants
Identification of disease-related T cell clones and arthritogenic antigens in ankylosing spondylitis
强直性脊柱炎疾病相关 T 细胞克隆和致关节炎抗原的鉴定
  • 批准号:
    413277889
  • 财政年份:
    2018
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Research Grants
Macrophage migration inhibitory factor (MIF) as a Crucial Regulatory Cytokine and Therapeutic Target in Ankylosing Spondylitis
巨噬细胞迁移抑制因子(MIF)作为强直性脊柱炎的关键调节细胞因子和治疗靶点
  • 批准号:
    397552
  • 财政年份:
    2018
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Fellowship Programs
Solving the causes of and development of new therapies for ankylosing spondylitis and related diseases
解决强直性脊柱炎及相关疾病的病因并开发新疗法
  • 批准号:
    nhmrc : GNT1118005
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Research Fellowships
Solving the causes of and development of new therapies for ankylosing spondylitis and related diseases
解决强直性脊柱炎及相关疾病的病因并开发新疗法
  • 批准号:
    nhmrc : 1118005
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Research Fellowships
Development and application of a Mendelian randomization framework aimed at dissecting the biological basis of ankylosing spondylitis and other complex diseases
孟德尔随机化框架的开发和应用,旨在剖析强直性脊柱炎和其他复杂疾病的生物学基础
  • 批准号:
    nhmrc : GNT1125200
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Project Grants
Personalized medicine for ankylosing spondylitis
强直性脊柱炎个体化用药
  • 批准号:
    365355
  • 财政年份:
    2017
  • 资助金额:
    $ 57.07万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了